Seeking Alpha

Amylin Pharmaceuticals (AMLN) rises 5.6% after activist investors Carl Icahn and Eastbourne...

Amylin Pharmaceuticals (AMLN) rises 5.6% after activist investors Carl Icahn and Eastbourne Capital Management each gain at least one seat on the board. The dissidents got strong support from high-profile proxy advisory firms, which may have impacted the vote.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs